Glioblastoma (GBM)Phase 1/2NCT07346144Papers
TGX-007
An AAV Mediated Dual-Payload Gene Therapy in Patients With High Grade Glioma
RNA-lipid Particle (RNA-LP) Vaccines for Newly Diagnosed Pediatric High-Grade Gliomas (pHGG) and Adult Glioblastoma (GBM)
What the film says
Glioblastoma hides from the immune system. Few immune cells go in, and those that do fall quiet. Vaccines have mostly failed to wake anything.
The idea: make the body think the tumor is a virus.
After surgery, the patient's own tumor is ground up and its messenger RNA copied, wrapped in layers of fat particles like an onion, and infused into a vein. To the immune system, foreign RNA looks like an infection. Alarms ring, aimed at the tumor's own genes.
In the first four adults, immune activity surged within two days. In pet dogs with brain tumors, survival lengthened.
PNOC020, at Florida and Children's National with Lindsay Kilburn, now tests it in children and adults, safety first. Public record; not medical advice.
Sources behind this film
Weller M. Lancet Oncol, 2017
Glioblastoma is immunologically "cold"; vaccines have mostly failed
Glioblastoma is immunologically "cold"; vaccines have mostly failed; Also includes pp65 LAMP mRNA; PNOC020 at Florida and Children's National with Lindsay Kilburn; children and adults; safety and MTD first
Mendez-Gomez HR. Cell, 2024
Patient's own tumor mRNA, amplified, wrapped in multilamellar lipid particles, given IV; looks like a viral infection; rapid response; Immune activity surged within two days in the first adults
Carrera-Justiz S. J Immunother Cancer, 2025
Pet dogs with brain tumors lived longer
The drug
RNA-LP vaccines will be administered intravenous. Three RNA-LP vaccines will be administered every 2 weeks followed by 12 cycles of adjuvant monthly RNA-LP vaccines for a total of 15 vaccines.
This is a first in human Phase I study of RNA-LP vaccines for newly diagnosed adult MGMT unmethylated (low level or undetected) glioblastoma (GBM) and pediatric patients with newly diagnosed HGG (pHGG). The phase I portion of the study will involve a dose-escalation study to identify the maximally tolerated dose (MTD). The GBM portion of the study is single site (UF) and the pediatric portion will be multisite.
This clinical trial will consist of three parts: Surgery, Radiation, and Immunotherapy. Surgery and chemoradiation will be standard of care for patients with GBM. Potentially eligible participants will be enrolled on a screening consent for the sterile collection of tumor material in a manner suitable for RNA extraction, amplification, and loading of lipid particles (LPs).
The study
The primary objective will be to demonstrate the manufacturing feasibility and safety, and to determine the maximum tolerated dose (MTD) of RNA-LP vaccines in (Stratum 1) adult patients with newly diagnosed GBM (MGMT low level or unmethylated in adults only) and (Stratum 2) in pediatric patients with newly diagnosed HGG (pHGG). Funding Source - FDA OOPD
Eligibility
Inclusion criteria as written on the registry, trimmed. The full list, with exclusions, is on the live record.
For you, or someone you love
A complex diagnosis brings new questions every week, in a trial and out of one. Triangle keeps your whole medical file together, reads it with you in plain language, and helps you and your family decide what to ask next.
Then $9 a month. Cancel anytime.
Requested from your hospitals and clinics through the national networks. Add scans, pathology and anything on paper.
Reports explained as they come in, with lab values you can follow before treatment, during a trial and after.
Ask about your own file, and walk in with questions for your oncologist or the trial team.
Share one profile with the family helping you, and with your doctors.
Members also get a deeper analysis of their records and any sequencing data, including clinical trials that may fit, reviewed by a licensed physician before they receive it.
It turns into a project to manage: visits, scans, labs, side effects and paperwork. Triangle keeps it organized in one place for you or for whoever's helping.
Organize my trial7-day free trial, then $9 a month. Cancel anytime.
How these trials work: what Phase 1 actually is · common questions Not clinical evidence.